Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STEMCELL Technologies is a global biotechnology company that develops and manufactures high-quality cell culture media, cell separation technologies, and accessory products for life science research. Founded in 1993 and headquartered in Vancouver, Canada, the company is a leader in providing standardized reagents for stem cell, immunology, cancer, and regenerative medicine research. Its product portfolio includes the well-known MethoCult and EasySep brands, which are used by scientists worldwide to isolate and culture various cell types. As a "Scientists Helping Scientists" company, STEMCELL also offers contract research services, training programs, and proficiency testing to support the global scientific community. With over 2,300 employees and a presence in over 100 countries, it is Canada's largest biotechnology company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell.